...
首页> 外文期刊>ACS catalysis >Enzymatic Reduction of Nicotinamide Biomimetic Cofactors Using an Engineered Glucose Dehydrogenase: Providing a Regeneration System for Artificial Cofactors
【24h】

Enzymatic Reduction of Nicotinamide Biomimetic Cofactors Using an Engineered Glucose Dehydrogenase: Providing a Regeneration System for Artificial Cofactors

机译:使用工程葡萄糖脱氢酶酶促减少烟酰胺酰胺辅助型辅助剂:为人造辅因子提供再生系统

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The increasing demand for chiral compounds supports the development of enzymatic processes. Dehydrogenases are often the enzymes of choice due to their high enantioselectivity combined with broad substrate acceptance. However, their requirement on costly NAD(P)/H as cofactor has sparked interest in the development of biomimetic derivatives that are easy to synthesize and, therefore, less expensive. Until now, few reactions with biomimetics have been described and regeneration is limited to nonenzymatic means, which are not suitable for incorporation and in situ approaches. Herein, we describe a regeneration enzyme, glucose dehydrogenase from Sulfolobus solfataricus (SsGDH), and demonstrate its activity with different biomimetics with the structure nicotinamide ring-alkyl chain-phenyl ring. Subsequent enzyme engineering resulted in the double mutant SsGDH Ile192Thr/Val306Ile, which had a 10-fold higher activity with one of the biomimetics compared with the wild-type enzyme. Using this engineered variant in combination with an enoate reductase from Therm us scotoductus resulted in the first enzyme-coupled regeneration process for biomimetic cofactor without ribonucleotide or ribonucleotide analogue and full conversion of 10 mM 2-methylbut-2-enal with 1-phenethyl-1,4-dihydropyridine-3-carboxamide as cofactor.
机译:对手性化合物的不断增加支持酶促过程的发展。脱氢酶通常是由于其高对映选择性与宽基底接受相结合的选择酶。然而,它们对昂贵的NAD(P)/ H作为辅助因子的要求引发了易于合成的仿生衍生物的兴趣,因此,更便宜。到目前为止,已经描述了少量与生物体的反应,并且再生限于非酶手段,其不适合于掺入和原位方法。在此,我们描述了来自磺酰桶溶含量(SSGDH)的再生酶,葡萄糖脱氢酶,并用不同的生物体与结构烟酰胺环 - 烷基链 - 苯环展示其活性。随后的酶工程导致双突变体SSGDH ILE192THR / VAL306 ille,其与野生型酶相比具有一种生物质的活性为10倍。使用该工程化变体与来自Therm US Scotoductus的Enoate还原酶组合导致用于生物摩擦辅因子的第一种酶偶联再生过程,而没有核糖核苷酸或核糖核苷酸类似物和10mM 2-甲基对-2-en的全转化为1-苯乙基-1 ,4-二氢吡啶-3-甲酰胺作为辅助因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号